A multicentre non-interventional study to assess the real-world effectiveness of Ocrelizumab in patients with relapsing or primary progressive multiple sclerosis – The MuSicalE STUDY

drug protocol number
MN39889
drug sponsor
Roche
drug study
Ocrelizumab (Ocrevus)
drug trial site
King Abdulaziz Medical City NG (Riyadh)
drug status
Ongoing
drug phase